Literature DB >> 27647056

Effectiveness of the Tobacco Tactics Program in the Trinity Health System.

Sonia A Duffy1, David L Ronis2, Carrie A Karvonen-Gutierrez3, Lee A Ewing4, Stephanie V Hall4, James J Yang2, Patricia L Thomas5, Christine M Olree6, Kimberly A Maguire7, Lisa Friedman8, Donna Gray9, Neil Jordan10.   

Abstract

INTRODUCTION: This study determined the effectiveness of the Tobacco Tactics intervention. DESIGN/SETTING/PARTICIPANTS: This was a pragmatic, quasi-experimental study conducted from 2010 to 2013 and analyzed from 2014 to 2015 in five Michigan community hospitals; three received the Tobacco Tactics intervention, and two received usual care. Smokers (N=1,528) were identified during hospitalization, and sent surveys and cotinine tests after 6 months. Changes in pre- to post-intervention quit rates in the intervention sites were compared with usual care control sites. INTERVENTION: The toolkit for nurses included: (1) 1 continuing education unit contact hour for training; (2) a PowerPoint presentation on behavioral and pharmaceutical interventions; (3) a pocket card entitled "Helping Smokers Quit: A Guide for Clinicians"; (4) behavioral and pharmaceutical protocols; and (5) a computerized template for documentation. The toolkit for patients included: (1) a brochure; (2) a cessation DVD; (3) the Tobacco Tactics manual; (4) a 1-800-QUIT-NOW card; (5) nurse behavioral counseling and pharmaceuticals; (6) physician reminders to offer brief advice to quit coupled with medication sign-off; and (7) follow-up phone calls by trained hospital volunteers. MAIN OUTCOME MEASURES: The effectiveness of the intervention was measured by 6-month 30-day point prevalence; self-reported quit rates with NicAlert(®) urinary biochemical verification (48-hour detection period); and the use of electronic medical record data among non-responders.
RESULTS: There were significant improvements in pre- to post-intervention self-reported quit rates (5.7% vs 16.5%, p<0.001) and cotinine-verified quit rates (4.3% vs 8.0%, p<0.05) in the intervention sites compared with no change in the control sites. Propensity-adjusted multivariable analyses showed a significant improvement in self-reported 6-month quit rates from the pre- to post-intervention time periods in the intervention sites compared to the control sites (p=0.044) and a non-statistically significant improvement in the cotinine-verified 6-month quit rate.
CONCLUSIONS: The Tobacco Tactics intervention, which meets the Joint Commission standards for inpatient smoking, has the potential to significantly decrease smoking among inpatient smokers. TRIAL REGISTRATION: This study is registered at www.clinicaltrial.gov NCT01309217. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27647056      PMCID: PMC5031413          DOI: 10.1016/j.amepre.2016.03.012

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  33 in total

1.  Why assigning ongoing tobacco use is not necessarily a conservative approach to handling missing tobacco cessation outcomes.

Authors:  David B Nelson; Melissa R Partin; Steven S Fu; Anne M Joseph; Lawrence C An
Journal:  Nicotine Tob Res       Date:  2009-01-27       Impact factor: 4.244

2.  Smoking cessation for hospitalized smokers: an evaluation of the "Ottawa Model".

Authors:  Robert D Reid; Kerri-Anne Mullen; Monika E Slovinec D'Angelo; Debbie A Aitken; Sophia Papadakis; Patricia M Haley; Christine A McLaughlin; Andrew L Pipe
Journal:  Nicotine Tob Res       Date:  2009-11-10       Impact factor: 4.244

3.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

4.  Proactive telephone counseling for smoking cessation: meta-analyses by recruitment channel and methodological quality.

Authors:  Flora Tzelepis; Christine L Paul; Raoul A Walsh; Patrick McElduff; Jenny Knight
Journal:  J Natl Cancer Inst       Date:  2011-06-10       Impact factor: 13.506

5.  Implementing Best Evidence in Smoking Cessation Treatment for Hospitalized Veterans: Results from the VA-BEST Trial.

Authors:  David A Katz; John E Holman; Skyler R Johnson; Stephen L Hillis; Susan L Adams; Steven S Fu; Kathleen M Grant; Lynne M Buchanan; Allan Prochazka; Catherine T Battaglia; Marita G Titler; Anne M Joseph; Mark Vander W Weg
Journal:  Jt Comm J Qual Patient Saf       Date:  2014-11

6.  Cigarette smoking, nicotine dependence, and motivation for smoking cessation in psychiatric inpatients.

Authors:  Heidi Solty; David Crockford; William D White; Shawn Currie
Journal:  Can J Psychiatry       Date:  2009-01       Impact factor: 4.356

7.  Predictors of quitting in hospitalized smokers.

Authors:  Harry Lando; Deborah Hennrikus; Maribet McCarty; John Vessey
Journal:  Nicotine Tob Res       Date:  2003-04       Impact factor: 4.244

8.  Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers treated with transdermal nicotine replacement: a randomized trial.

Authors:  Joel A Simon; Timothy P Carmody; Esther S Hudes; Elizabeth Snyder; Jana Murray
Journal:  Am J Med       Date:  2003-05       Impact factor: 4.965

9.  Effectiveness of the tobacco tactics program in the Department of Veterans Affairs.

Authors:  Sonia A Duffy; David L Ronis; Carrie A Karvonen-Gutierrez; Lee A Ewing; Gregory W Dalack; Patricia M Smith; Timothy P Carmody; Thomas Hicks; Christopher Hermann; Pamela Reeves; Petra Flanagan
Journal:  Ann Behav Med       Date:  2014-10

10.  Dissemination of the nurse-administered Tobacco Tactics intervention versus usual care in six Trinity community hospitals: study protocol for a comparative effectiveness trial.

Authors:  Sonia A Duffy; David L Ronis; Marita G Titler; Frederic C Blow; Neil Jordan; Patricia L Thomas; Gay L Landstrom; Lee A Ewing; Andrea H Waltje
Journal:  Trials       Date:  2012-08-01       Impact factor: 2.279

View more
  6 in total

1.  Implementing Motivational Interviewing for Substance Misuse on Medical Inpatient Units: a Randomized Controlled Trial.

Authors:  Steve Martino; Paula Zimbrean; Ariadna Forray; Joy S Kaufman; Paul H Desan; Todd A Olmstead; Kathryn Gilstad-Hayden; Ralitza Gueorguieva; Kimberly A Yonkers
Journal:  J Gen Intern Med       Date:  2019-08-29       Impact factor: 5.128

2.  Evaluation of a Systems-Based Tobacco Cessation Program Using Bedside Volunteers.

Authors:  Denise S Taylor; Dominique Medaglio; Claudine T Jurkovitz; Freda Patterson; Zugui Zhang; Adebayo Gbadebo; Elisabeth Bradley; Rose Wessells; Edward Goldenberg
Journal:  Nicotine Tob Res       Date:  2020-03-16       Impact factor: 4.244

3.  Tobacco Use Prevalence and Smoking Cessation Pharmacotherapy Prescription Patterns Among Hospitalized Patients by Medical Specialty.

Authors:  A Benjamin Srivastava; Alex T Ramsey; Leslie D McIntosh; Thomas C Bailey; Sherri L Fisher; Louis Fox; Mario Castro; Yinjiao Ma; Timothy B Baker; Li-Shiun Chen; Laura J Bierut
Journal:  Nicotine Tob Res       Date:  2019-04-17       Impact factor: 4.244

4.  Impact of the 2015 CMS Inpatient Psychiatric Facility Quality Reporting Rule on Tobacco Treatment.

Authors:  Shane Carrillo; Niaman Nazir; Eric Howser; Lisa Shenkman; Melinda Laxson; Taenisha S Scheuermann; Kimber P Richter
Journal:  Nicotine Tob Res       Date:  2017-08-01       Impact factor: 4.244

5.  Implementation of the Tobacco Tactics intervention versus usual care in Trinity Health community hospitals.

Authors:  Sonia A Duffy; David L Ronis; Lee A Ewing; Andrea H Waltje; Stephanie V Hall; Patricia L Thomas; Christine M Olree; Kimberly A Maguire; Lisa Friedman; Sue Klotz; Neil Jordan; Gay L Landstrom
Journal:  Implement Sci       Date:  2016-11-04       Impact factor: 7.327

6.  Quantifying rural disparity in healthcare utilization in the United States: Analysis of a large midwestern healthcare system.

Authors:  Akua Nuako; Jingxia Liu; Giang Pham; Nina Smock; Aimee James; Timothy Baker; Laura Bierut; Graham Colditz; Li-Shiun Chen
Journal:  PLoS One       Date:  2022-02-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.